News
AEMD
1.415
-0.35%
-0.005
Weekly Report: what happened at AEMD last week (0408-0412)?
Weekly Report · 3d ago
WHO's Tedros Adhanom Ghebreyesus Posts On X "In #DRC alone, more than 4500 cases of #mpox and almost 300 deaths have been reported this year. That is triple the number reported at this time last year. The recent surge in cases and deaths among children is of particular concern, along with the re-emergence of Clade One in central Africa...."
Benzinga · 04/11 14:09
Weekly Report: what happened at AEMD last week (0401-0405)?
Weekly Report · 04/08 11:28
BRIEF-Aethlon Medical Files For Offering Of Up To 4.65 Million Shares Of Common Stock
Aethlon Medical Inc Files For Offering Of Up To 4.65 Million Shares Of Common Stock. The company is a subsidiary of Aethlon Pharmaceuticals Inc. The offering is expected to raise up to $100 million in the first quarter of 2013. The shares are expected to be sold on the Nasdaq.
Reuters · 04/05 21:33
Weekly Report: what happened at AEMD last week (0325-0329)?
Weekly Report · 04/01 11:26
Weekly Report: what happened at AEMD last week (0318-0322)?
Weekly Report · 03/25 11:29
Aethlon Medical files to sell common stock, warrants
Seeking Alpha · 03/22 21:22
Weekly Report: what happened at AEMD last week (0311-0315)?
Weekly Report · 03/18 11:27
Weekly Report: what happened at AEMD last week (0304-0308)?
Weekly Report · 03/11 11:23
Aethlon Medical Price Target Cut to $10.00/Share From $23.00 by HC Wainwright & Co.
Dow Jones · 03/04 13:58
Aethlon Medical Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 03/04 13:58
HC Wainwright & Co. Maintains Buy on Aethlon Medical, Lowers Price Target to $10
Benzinga · 03/04 13:48
Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB), Aethlon Medical (AEMD) and Aclaris Therapeutics (ACRS)
TipRanks · 03/04 11:31
Weekly Report: what happened at AEMD last week (0226-0301)?
Weekly Report · 03/04 11:26
Weekly Report: what happened at AEMD last week (0219-0223)?
Weekly Report · 02/26 11:41
Aethlon Inks Materials Transfer Deal For Santersus' NucleoCapture And HemoNucleoCapture Devices
NASDAQ · 02/21 14:16
Weekly Report: what happened at AEMD last week (0212-0216)?
Weekly Report · 02/19 11:43
Maxim Group Sticks to Their Hold Rating for Aethlon Medical (AEMD)
TipRanks · 02/16 12:57
Aethlon Medical Inc reports results for the quarter ended in December - Earnings Summary
Aethlon Medical Inc reports results for the quarter ended in December. The company reported a quarterly adjusted loss of $1.37 per share. Reported revenue was zero; analysts expected zero. Aethlon medical Inc shares had fallen by 21.0% this quarter.
Reuters · 02/15 04:32
Aethlon Medical GAAP EPS of -$1.37 in-line
Seeking Alpha · 02/14 21:45
More
Webull provides a variety of real-time AEMD stock news. You can receive the latest news about Aethlon Medical through multiple platforms. This information may help you make smarter investment decisions.
About AEMD
Aethlon Medical, Inc. (Aethlon) is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections suppression, seed the spread of metastasis and inhibit the benefit of cancer therapies. The Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression. Hemopurifier helps to bind and clear multiple different glycosylated viruses, such as human immunodeficiency virus (HIV), hepatitis C virus (HCV), Dengue, West Nile, multiple strains of influenza, Ebola, Chikungunya, smallpox, monkeypox, multiple herpes viruses, a MERS-CoV related pseudovirus, and others. Hemopurifier is used as a device for two independent indications: the treatment of individuals with advanced or metastatic cancer and the treatment of life threating viruses that are not approved therapies.